Form 8-K - Current report:
SEC Accession No. 0001193125-24-159261
Filing Date
2024-06-12
Accepted
2024-06-11 17:42:31
Documents
13
Period of Report
2024-06-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d816080d8k.htm   iXBRL 8-K 25635
  Complete submission text file 0001193125-24-159261.txt   148222

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA gral-20240611.xsd EX-101.SCH 2878
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE gral-20240611_lab.xml EX-101.LAB 17979
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gral-20240611_pre.xml EX-101.PRE 11277
16 EXTRACTED XBRL INSTANCE DOCUMENT d816080d8k_htm.xml XML 3626
Mailing Address 1525 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address 1525 O'BRIEN DRIVE MENLO PARK CA 94025 650-771-9796
GRAIL, LLC (Filer) CIK: 0001699031 (see all company filings)

EIN.: 475117880 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42045 | Film No.: 241036922
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)